Skip to main content

Advertisement

SpringerLink
Log in

An idiopathic thrombocytopenic purpura with polyneuropathy

  • Therapeutic Aspects in Autoimmunity
  • Published:
Immunologic Research Aims and scope Submit manuscript

Abstract

Concurrent association of idiopathic thrombocytopenic purpura (ITP) and peripheral neuropathy is a rare condition. There are only few case reports published concerning peripheral neuropathy with ITP. One of the etiopathogenetic mechanisms proposed is intraneural hemorrhage, but the pathogenesis is not fully understood. Autoimmune nature with common antibodies to the platelets and the nerve´s myelin sheath should also be considered. Here we describe a 47-year-old woman, with a family history of autoimmune diseases. She was diagnosed 2 years ago with ITP and later developed a chronic combined inflammatory demyelinating polyneuropathy. Treatment with high-dose steroids was initiated with a poor response. The patient showed a clear improvement in platelet count and in the peripheral neuropathy symptoms when treatment with intravenous immunoglobulin was administered. Common etiologic mechanism of the two diseases should be considered, both, because of the simultaneous time of development and a similar response to intravenous immunoglobulin treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Greenberg Michael K, Sonoda T. Mononeuropathy multiplex complicating idiopathic thrombocytopenic purpura. Neurology. 1991;41:1517–818.

    Article  Google Scholar 

  2. Silverstein A. Neuropathy in hemophilia. JAMA. 1964;190:554–5.

    Article  CAS  PubMed  Google Scholar 

  3. Bigelow NH, Graves RN. Peripheral nerve lesions in hemorrhagic diseases. Arch Neurol Psychiat. 1952;68:819–30.

    Article  CAS  Google Scholar 

  4. Brun A, Caviness V, Rudnick P, Tayler HR. Hemorrhages into peripheral nerves in association with leukemia. J Neuropathol Exp Neurol. 1964;23:719–25.

    Article  CAS  PubMed  Google Scholar 

  5. Cordinegley FT, Crawford GPM. Ulnar nerve palsy in the haemophiliac due to intraneural haemorrhage. Br Med J. 1984;289:18–9.

    Article  Google Scholar 

  6. Miyao S, Takano A, Teramoto J, Fujitake S, Hashizume Y. Oculomotor nerve palsy due to intraneural hemorrhage in idiopathic thrombocytopenic purpura: a case report. Eur Neurol. 1993;33:20–2.

    Article  CAS  PubMed  Google Scholar 

  7. Gianpolo Antony J, Giuliani Michael J. ITP and neuropathy. To the editor. Neurology. 1993;43:847.

    Article  Google Scholar 

  8. Ward IM, Fewell AE, Ferraro DM, Morris MJ. Concurrent acute motor and sensory axonal neuropathy and immune thrombocytopenic purpura. Mil Med. 2013;178(3):e367.

    Article  PubMed  Google Scholar 

  9. Shoenfeld Y, Gilburd B, Abu-Shakra M, Amital H, Barzilai O, Berkun Y, Blank M, Zandman-Goddard G, Katz U, Krause I, Langevitz P, Levy Y, Orbach H, Pordeus V, Ram M, Sherer Y, Toubi E, Tomer Y. The mosaic of autoimmunity: genetic factors involved in autoimmune diseases. Isr Med Assoc J. 2008;10:3–7.

    PubMed  Google Scholar 

  10. Shoenfeld Y, Zandman-Goddard G, Stojanovich L, Cutolo M, Amital H, Levy Y, Abu-Shakra M, Barzilai O, Berkun Y, Blank M, Freire de Carvalho J, Doria A, Gilburd B, Katz U, Krause I, Langevitz P, Orbach H, Pordeus V, Ram M, Toubi E, Sherer Y. The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases. Isr Med Assoc J. 2008;10:8–12.

    PubMed  Google Scholar 

  11. Shoenfeld Y, Blank M, Abu-Shakra M, Amital H, Barzilai O, Berkun Y, Bizzaro N, Gilburd B, Zandman-Goddard G, Katz U, Krause I, Langevitz P, Mackay IR, Orbach H, Ram M, Sherer Y, Toubi E, Eric Gershwin M. The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases. Isr Med Assoc J. 2008;10:13–9.

    PubMed  Google Scholar 

  12. Hughes RA, Cornblath DR. Guillain-Barre´ syndrome. Lancet. 2005;366:1653–66.

    Article  CAS  PubMed  Google Scholar 

  13. Sato N, Kamata T, Akiyama N, Kuwana M, Kanda T. Acute inflammatory sensorimotor polyradiculoneuropathy associated with immune thrombocytopenic purpura. J Intern Med. 2005;257:473–7.

    Article  CAS  PubMed  Google Scholar 

  14. Harati Y, Bosch EP. Disorders of peripheral nerves. In: Bradley WG, Daroff RB, Fenichel GM, Jankovic J, editors. Bradley’s neurology in clinical practice, vol. 2, 5th ed. Philadelphia: Butterworth-Heinemann Elsevier; 2008. p. 2288–2296.

  15. Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011;117:4190–207.

    Article  CAS  PubMed  Google Scholar 

  16. Van den Bergh PY, Hadden RD, Bouche P, et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society—first revision. Eur J Neurol. 2010;17:356.

    Article  PubMed  Google Scholar 

  17. Patwa HS, Chaudhry V, Katzberg H, et al. Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2012;78:1009.

    Article  CAS  PubMed  Google Scholar 

  18. Godeau B, Chevret S, Varet B, et al. Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial. Lancet. 2002;359:23.

    Article  CAS  PubMed  Google Scholar 

  19. Hughes R, Bensa S, Willison H, et al. Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol. 2001;50:195.

    Article  CAS  PubMed  Google Scholar 

  20. Dyck PJ, Litchy WJ, Kratz KM, et al. A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol. 1994;36:838.

    Article  CAS  PubMed  Google Scholar 

  21. Eftimov F, Winer JB, Vermeulen M, et al. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev. 2013;12:CD001797.

    Google Scholar 

  22. Godeau B, Caulier MT, Decuypere L, et al. Intravenous immunoglobulin for adults with autoimmune thrombocytopenic purpura: results of a randomized trial comparing 0.5 and 1 g/kg b.w. Br J Haematol. 1999;107:716.

    Article  CAS  PubMed  Google Scholar 

  23. Schwartz-Albiez R, Monteiro RC, Rodriguez M, Binder CJ, Shoenfeld Y. Natural antibodies, intravenous immunoglobulin and their role in autoimmunity, cancer and inflammation. Clin Exp Immunol. 2009;158(Suppl 1):43–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Shoenfeld Y, Fishman P. Gamma-globulin inhibits tumour spread in mice. Int Immunol. 1999;11:1247–51.

    Article  CAS  PubMed  Google Scholar 

  25. Shapiro S, Shoenfeld Y, Gilburd B, et al. Intravenous gamma globulin inhibits the production of matrix metalloproteinase-9 in macrophages. Cancer. 2002;95:2032–7.

    Article  CAS  PubMed  Google Scholar 

  26. Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113:2386.

    Article  CAS  PubMed  Google Scholar 

  27. Ghanima W, Godeau B, Cines DB, Bussel JB. How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment. Blood. 2012;120:960.

    Article  CAS  PubMed  Google Scholar 

  28. George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996;88:3.

    CAS  PubMed  Google Scholar 

  29. Toltl LJ, Arnold DM. Pathophysiology and management of chronic immune thrombocytopenia: focusing on what matters. Br J Haematol. 2011;152:52.

    Article  PubMed  Google Scholar 

  30. Mendell JR, Barohn RJ, Freimer ML, et al. Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy. Neurology. 2001;56:445.

    Article  CAS  PubMed  Google Scholar 

  31. Cornblath DR, Gorson KC, Hughes RA, Merkies IS. Observations on chronic inflammatory demyelinating polyneuropathy: a plea for a rigorous approach to diagnosis and treatment. J Neurol Sci. 2013;330:2.

    Article  PubMed  Google Scholar 

  32. Gorson KC, van Schaik IN, Merkies IS, et al. Chronic inflammatory demyelinating polyneuropathy disease activity status: recommendations for clinical research standards and use in clinical practice. J Peripher Nerv Syst. 2010;15:326.

    Article  PubMed  Google Scholar 

  33. Eftimov F, Vermeulen M, van Doorn PA, et al. Long-term remission of CIDP after pulsed dexamethasone or short-term prednisolone treatment. Neurology. 2012;78:1079.

    Article  CAS  PubMed  Google Scholar 

  34. Pollard JD, Armati PJ. CIDP—the relevance of recent advances in Schwann cell/axonal neurobiology. J Peripher Nerv Syst. 2011;16:15–23.

    Article  PubMed  Google Scholar 

  35. Dacci P, Riva N, Scarlato M, et al. Subcutaneous immunoglobulin therapy for the treatment of multifocal motor neuropathy: a case report. Neural Sci. 2010;31:829–31.

    Article  Google Scholar 

  36. Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society. European Federation of management of multifocal motor neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society—first revision. J Peripher Nerv Syst. 2010;15:295–301.

    Article  Google Scholar 

  37. Léger JM. Immunoglobulin (IG) in multifocal motor neuropathy (MMN): update on evidence for Ig treatment in MMN. Clin Exp Immunol. 2014;178:42–4.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Léger JM, Viala K, Cancalon F, et al. Intravenous Immunoglobulin as short- and long-term therapy for multifocal motor neuropathy: a retrospective study of response to IVIg and of its predictive criteria in 40 patients. J Neural Neurosurg Psychiatry. 2008;79:93–6.

    Article  Google Scholar 

  39. Van den Berg-Vos RM, Franssen H, Wokke JH, Van den Berg LH. Multifocal motor neuropathy: long-term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatment. Brain. 2002;125:1875–86.

    Article  PubMed  Google Scholar 

  40. Terenghi F, Cappellari A, Bersano A, Carpo M, Barbieri S, Nobile-Orazio E. How long is IVIg effective in multifocal motor neuropathy? Neurology. 2004;62:666–8.

    Article  CAS  PubMed  Google Scholar 

  41. Vucic S, Black KR, Chong PS, Cros D. Multifocal neuropathy: decrease in conduction blocks and reinnervation with long-term IVIg. Neurology. 2004;63:1264–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departamento de Medicina Interna, Hospital La Paz, Madrid, Spain

    Valeria Katchan

  2. Faculdade de Ciências Médicas, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil

    Paula David

  3. Zabludowicz Center for Autoimmune Diseases, Chaim Sheba Medical Center, 52621, Tel-Hashomer, Israel

    Valeria Katchan, Paula David & Yehuda Shoenfeld

  4. Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel

    Yehuda Shoenfeld

Authors
  1. Valeria Katchan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paula David
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yehuda Shoenfeld
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yehuda Shoenfeld.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Katchan, V., David, P. & Shoenfeld, Y. An idiopathic thrombocytopenic purpura with polyneuropathy. Immunol Res 65, 193–196 (2017). https://doi.org/10.1007/s12026-016-8828-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12026-016-8828-4

Keywords

Search

Navigation